SCHEMBL23861632

SCHEMBL23861632

CC(C)(c1c(O)ccc2ccc(O)cc12)c1c(O)ccc2ccc(Oc3ccc4ccccc4c3)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ GAA P10253 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ ESR1 P03372 2/20 0.38
▸ ESR2 Q92731 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ HAO1 Q9UJM8 1/20 0.38
▸ EGLN1 Q9GZT9 2/20 0.37
▸ EGLN2 Q96KS0 1/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861487 0.79 CYP1A2 (0.46) MEN1KMT2AGAAMAPTCYP1A2
SCHEMBL9618414 0.75 ESR1 (0.47) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL31356444 0.74 PTPN22 (0.54) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL20398800 0.74 PTPN22 (0.54) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL18674135 0.73 CYP1A2 (0.52) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL2186567 0.72 LMNA (0.50) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL29493119 0.72 LMNA (0.50) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL8956007 0.72 CYP1A2 (0.56) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL11176472 0.72 LTA4H (0.64) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL23861459 0.71 CYP2C9 (0.44) MEN1KMT2AALDH1A1HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 MEN1 4292/4885KMT2A 1279/4885GAA 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback